Skip to content
NYSEDHR
Danaher Announces Pricing of Senior Notes Offering
PRNewswire-FirstCall
WASHINGTON

Danaher Corporation announced today that it has priced a public offering of $750 million of its 5.40% senior notes due 2019.

Danaher expects to receive net proceeds, after expenses, of approximately $744 million. Danaher intends to use the net proceeds from this offering to repay all or a portion of Danaher's outstanding commercial paper and for other general corporate purposes. The offering is expected to close on March 5, 2009.

Banc of America Securities LLC, Deutsche Bank Securities Inc. and Goldman, Sachs & Co. are acting as joint book-running managers.

The offering is being made pursuant to an effective registration statement filed by Danaher Corporation with the Securities and Exchange Commission on July 14, 2006.

The offering of the senior notes may be made only by means of a prospectus. A copy of the prospectus and prospectus supplement relating to the senior notes can be obtained from Banc of America Securities LLC's Prospectus Department at 100 West 33rd Street New York, NY 10001, telephone 1-800-294-1322, email dg.prospectus_distribution@bofasecurities.com; from Deutsche Bank Securities Inc. at Harborside Financial Center, 100 Plaza One, Floor 2, Jersey City, NY, 07311-3988. Attn: Prospectus Department, telephone 1-800-503-4611, email prospectusrequest@list.db.com; and from Goldman, Sachs & Co.'s Prospectus Department at 85 Broad Street, New York, NY 10004, telephone: 1-866-471-2526, facsimile: 1-212-902-9316, email: prospectus-ny@ny.email.gs.com.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, Danaher's senior notes or any other securities, nor shall there be any sale of securities mentioned in this press release in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies and Tools and Components.

Statements in this document that are not strictly historical, including the issuance and sale of senior notes in the offering, may constitute forward looking statements. There are a number of risks and uncertainties that could cause actual results or events to differ materially from those suggested or indicated by such forward looking statements, including the factors described in Danaher's Annual Report on Form 10-K for the year ended December 31, 2008 and other SEC filings of Danaher. These forward looking statements speak only as of the date of this release and Danaher does not assume any obligation or intend to update any forward looking statement.

First Call Analyst:
FCMN Contact:

SOURCE: Danaher Corporation

CONTACT: Andy Wilson, Vice President, Investor Relations, of Danaher
Corporation, +1-202-828-0850, or Fax, +1-202-828-0860